Codex 5 billion 250 mg - lactic ferments 10 sachets

Product Description

Codex 5 Billion 250mg Antidiarrheal Sachets

Composition:

Codex 5 billion hard capsules Each capsule contains: active ingredient: Saccharomyces boulardii 5 billion live germs (in the form of 250 mg of lyophilized powder) Codex 5 billion powder for oral suspension Each sachet contains: active ingredient: Saccharomyces boulardii 5 billion live germs (in the form of 250 mg of lyophilized powder)

Excipients

Codex 5 billion hard capsules Each capsule contains: lactose, magnesium stearate, gelatin, titanium dioxide Codex 5 billion powder for oral suspension Each sachet contains: lactose monohydrate, fructose, colloidal anhydrous silica, tutti i frutti flavor.

Therapeutic indications

– Prophylaxis and treatment of intestinal dysbiosis induced by antibiotics and sulfonamides and of the vitamin deficiencies caused by them.
- Treatment of acute diarrhea of ​​various etiologies.
- Prophylaxis and treatment of "traveler's diarrhea".
- Treatment of irritable bowel syndrome with altered bowel habits.
- Treatment of candidiasis of the gastrointestinal tract.

Contraindications

Hypersensitivity to the active substance or to any of the excipients. Patients with a central venous catheter. Allergy to yeasts.

Dosage

Adults: 1–2 capsules/sachets twice a day. Children 0 to 3 years: 1 sachet twice a day. Children 3 to 12 years: 1 sachet 3 times a day. Unless otherwise prescribed by your doctor. It is recommended to administer Codex at regular intervals, preferably on an empty stomach or at least 15 minutes before meals. During treatment with antibiotics, administer Codex at the same time. For infants or children, it is recommended to pour the contents of the sachet into a bottle or into a little sugared liquid.

Warnings and precautions

Do not mix Codex with very hot liquids or alcoholic solutions. Given the fungal nature of Saccharomyces boulardii, Codex should not be administered during topical or systemic antifungal therapy. General information - Treatment of diarrhea is not a substitute for rehydration, when necessary. The amount of rehydration and its administration route must be commensurate with the severity of the diarrhea and the age and health of the patient. - As with all medicinal products based on living microorganisms, particular care must be taken when handling the product in the presence of patients with a central venous catheter to avoid any contamination by the hands and/or the spread of spores through the air. In fact, in patients with a central venous catheter, even if not treated with Saccharomyces boulardii, very rare cases of fungemia (spread of yeast in the blood) have been reported, most often manifesting with pyrexia and positive blood cultures for Saccharomyces strains. All these cases resolved favorably following treatment with antifungal agents and, where necessary, removal of the catheter. Important information about some of the excipients CODEX 5 billion hard capsules – contains lactose and is therefore not suitable for patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency, or glucose-galactose malabsorption. – does not contain gluten. CODEX 5 billion powder for oral suspension – contains lactose and fructose and is therefore not suitable for patients with rare hereditary problems of galactose or fructose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption. – does not contain gluten.

Interactions

Given the fungal nature of Saccharomyces boulardii, Codex should not be administered during topical or systemic antifungal therapy.

Side effects

Rare cases of flatulence have been reported following the administration of Codex, and very rare cases of allergic reactions in the form of facial swelling (angioedema) and/or itching, wheals (urticaria) and localized or systemic rash. Furthermore, very rare cases of anaphylactic reaction or shock have been reported.

Pregnancy and breastfeeding

There is no reliable information available regarding teratogenicity in animals. No cases of malformations or fetotoxic effects have been reported clinically. However, since data from monitoring pregnant women exposed to the drug are insufficient, all risks cannot be excluded. Although Saccharomyces boulardii is not absorbed, its administration during pregnancy and breastfeeding should be performed only if strictly necessary under the direct supervision of a doctor who will evaluate the risk/benefit ratio.

Format

10 sachets